Literature DB >> 28468972

Using Visualization of t-Distributed Stochastic Neighbor Embedding To Identify Immune Cell Subsets in Mouse Tumors.

Nicole V Acuff1, Joel Linden2,3.   

Abstract

High-dimensional flow cytometry is proving to be valuable for the study of subtle changes in tumor-associated immune cells. As flow panels become more complex, detection of minor immune cell populations by traditional gating using biaxial plots, or identification of populations that display small changes in multiple markers, may be overlooked. Visualization of t-distributed stochastic neighbor embedding (viSNE) is an unsupervised analytical tool designed to aid the analysis of high-dimensional cytometry data. In this study we use viSNE to analyze the simultaneous binding of 15 fluorophore-conjugated Abs and one cell viability probe to immune cells isolated from syngeneic mouse MB49 bladder tumors, spleens, and tumor-draining lymph nodes to identify patterns of anti-tumor immune responses. viSNE maps identified populations in multidimensional space of known immune cells, including T cells, B cells, eosinophils, neutrophils, dendritic cells, and NK cells. Based on the expression of CD86 and programmed cell death protein 1, CD8+ T cells were divided into distinct populations. Additionally, both CD8+ T cells and CD8+ dendritic cells were identified in the tumor microenvironment. Apparent differences between splenic and tumor polymorphonuclear cells/granulocytic myeloid-derived suppressor cells are due to the loss of CD44 upon enzymatic digestion of tumors. In conclusion, viSNE is a valuable tool for high-dimensional analysis of immune cells in tumor-bearing mice, which eliminates gating biases and identifies immune cell subsets that may be missed by traditional gating.
Copyright © 2017 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28468972      PMCID: PMC5890814          DOI: 10.4049/jimmunol.1602077

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  39 in total

1.  Most lymphoid organ dendritic cell types are phenotypically and functionally immature.

Authors:  Nicholas S Wilson; Dima El-Sukkari; Gabrielle T Belz; Christopher M Smith; Raymond J Steptoe; William R Heath; Ken Shortman; José A Villadangos
Journal:  Blood       Date:  2003-06-05       Impact factor: 22.113

Review 2.  Algorithmic Tools for Mining High-Dimensional Cytometry Data.

Authors:  Cariad Chester; Holden T Maecker
Journal:  J Immunol       Date:  2015-08-01       Impact factor: 5.422

3.  Methods for discovery and characterization of cell subsets in high dimensional mass cytometry data.

Authors:  Kirsten E Diggins; P Brent Ferrell; Jonathan M Irish
Journal:  Methods       Date:  2015-05-13       Impact factor: 3.608

4.  IL-2 upregulates CD86 expression on human CD4(+) and CD8(+) T cells.

Authors:  Ananta Paine; Hartmut Kirchner; Stephan Immenschuh; Mathias Oelke; Rainer Blasczyk; Britta Eiz-Vesper
Journal:  J Immunol       Date:  2012-01-13       Impact factor: 5.422

Review 5.  The biology of myeloid-derived suppressor cells: the blessing and the curse of morphological and functional heterogeneity.

Authors:  Je-In Youn; Dmitry I Gabrilovich
Journal:  Eur J Immunol       Date:  2010-11       Impact factor: 5.532

6.  Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired.

Authors:  Mojgan Ahmadzadeh; Laura A Johnson; Bianca Heemskerk; John R Wunderlich; Mark E Dudley; Donald E White; Steven A Rosenberg
Journal:  Blood       Date:  2009-05-07       Impact factor: 22.113

7.  MB49 murine urothelial carcinoma: molecular and phenotypic comparison to human cell lines as a model of the direct tumor response to bacillus Calmette-Guerin.

Authors:  Fanghong Chen; Guangjian Zhang; Yanli Cao; Martin J Hessner; William A See
Journal:  J Urol       Date:  2009-10-23       Impact factor: 7.450

8.  PD-1 expression on dendritic cells suppresses CD8+ T cell function and antitumor immunity.

Authors:  Tong Seng Lim; Valerie Chew; Je Lin Sieow; Siting Goh; Joe Poh-Sheng Yeong; Ai Ling Soon; Paola Ricciardi-Castagnoli
Journal:  Oncoimmunology       Date:  2015-08-31       Impact factor: 8.110

9.  Characterizing Phenotypes and Signaling Networks of Single Human Cells by Mass Cytometry.

Authors:  Nalin Leelatian; Kirsten E Diggins; Jonathan M Irish
Journal:  Methods Mol Biol       Date:  2015

10.  High-dimensional analysis of the murine myeloid cell system.

Authors:  Burkhard Becher; Andreas Schlitzer; Jinmiao Chen; Florian Mair; Hermi R Sumatoh; Karen Wei Weng Teng; Donovan Low; Christiane Ruedl; Paola Riccardi-Castagnoli; Michael Poidinger; Melanie Greter; Florent Ginhoux; Evan W Newell
Journal:  Nat Immunol       Date:  2014-10-12       Impact factor: 25.606

View more
  5 in total

1.  Identification of stem cells from large cell populations with topological scoring.

Authors:  Mihaela E Sardiu; Andrew C Box; Jeffrey S Haug; Michael P Washburn
Journal:  Mol Omics       Date:  2020-09-14

2.  Analyzing inter-reader variability affecting deep ensemble learning for COVID-19 detection in chest radiographs.

Authors:  Sivaramakrishnan Rajaraman; Sudhir Sornapudi; Philip O Alderson; Les R Folio; Sameer K Antani
Journal:  PLoS One       Date:  2020-11-12       Impact factor: 3.240

3.  Computational flow cytometric analysis to detect epidermal subpopulations in human skin.

Authors:  Lidan Zhang; Ying Cen; Qiaorong Huang; Huifang Li; Xianming Mo; Wentong Meng; Junjie Chen
Journal:  Biomed Eng Online       Date:  2021-02-17       Impact factor: 2.819

4.  Tumor microenvironment modulation enhances immunologic benefit of chemoradiotherapy.

Authors:  Aurelie Hanoteau; Jared M Newton; Rosemarie Krupar; Chen Huang; Hsuan-Chen Liu; Angelina Gaspero; Robyn D Gartrell; Yvonne M Saenger; Thomas D Hart; Saskia J Santegoets; Damya Laoui; Chad Spanos; Falguni Parikh; Padmini Jayaraman; Bing Zhang; Sjoerd H Van der Burg; Jo A Van Ginderachter; Cornelis J M Melief; Andrew G Sikora
Journal:  J Immunother Cancer       Date:  2019-01-15       Impact factor: 13.751

5.  Bulk and Single-Cell Profiling of Breast Tumors Identifies TREM-1 as a Dominant Immune Suppressive Marker Associated With Poor Outcomes.

Authors:  Ashok K Pullikuth; Eric D Routh; Kip D Zimmerman; Julia Chifman; Jeff W Chou; Michael H Soike; Guangxu Jin; Jing Su; Qianqian Song; Michael A Black; Cristin Print; Davide Bedognetti; Marissa Howard-McNatt; Stacey S O'Neill; Alexandra Thomas; Carl D Langefeld; Alexander B Sigalov; Yong Lu; Lance D Miller
Journal:  Front Oncol       Date:  2021-12-08       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.